A weight loss specialist and paediatric endocrinologist call for government funding of Wegovy, citing health benefits, equity concerns, and the need for proper medical oversight in treating obesity as a disease.
Stacked weekly counts; colour by editorial lean. Stuff and The Spinoff lean centre-left, NZ Herald centre-right, others centre.
How press outlets have named this topic, week by week.
Most recent 2 articles linking to this topic.
Up to 12 framings spread across outlets. Each framing is the LLM's one-line characterisation of the article's editorial angle — not a quote.
cost versus benefit debate
Can Wegovy move the needle on NZ’s obesity crisis, or simply treat its symptoms? - OpinionSocial-media signal on the same topic, drawn from the social lens. Engagement is likes + 2×shares + 3×replies, the same weighting used across the digest cards. View on /social →
Spotted something wrong on this page? Report a correction.